Loading briefing details...
Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Science & Environment
June 26, 2026
Creative Diagnostics has introduced a new suite of research reagents and products designed to assist scientists studying hantaviruses. The collection provides the essential materials needed to develop diagnostic tests and explore potential therapeutic options for these rodent-borne pathogens.
The product range includes recombinant antigens, along with monoclonal and polyclonal antibodies. These tools are compatible with various laboratory techniques, such as Western blot, flow cytometry, and ELISA, allowing for more precise detection of viral markers.
By offering standardized materials for multiple strains including Puumala, Seoul, and Sin Nombre viruses, the company aims to improve the consistency of research outcomes. These supplies are intended to support academic and industrial organizations working on urgent diagnostic and vaccine development projects.
Hantaviruses are identified by the CDC as serious pathogens that cause severe respiratory and renal conditions. Because initial symptoms often resemble common respiratory illnesses, the challenge of early detection remains a significant hurdle for public health systems. The current lack of available vaccines or specific antiviral treatments intensifies the need for reliable diagnostic tools.
As zoonotic diseases continue to pose global risks, there is a growing industry trend toward providing high-quality, standardized components for research. By simplifying the availability of viral proteins and detection antibodies, companies are helping accelerate the timeline for drug discovery and the creation of accurate clinical diagnostic assays.